Home >> Research Area >>Proteases/Proteasome>>ACE>> Enalaprilat Dihydrate

Enalaprilat Dihydrate

CAS# 84680-54-6

Enalaprilat Dihydrate

Catalog No. BCC5009----Order now to get a substantial discount!

Product Name & Size Price Stock
Enalaprilat Dihydrate: 5mg $12 In Stock
Enalaprilat Dihydrate: 10mg Please Inquire In Stock
Enalaprilat Dihydrate: 20mg Please Inquire Please Inquire
Enalaprilat Dihydrate: 50mg Please Inquire Please Inquire
Enalaprilat Dihydrate: 100mg Please Inquire Please Inquire
Enalaprilat Dihydrate: 200mg Please Inquire Please Inquire
Enalaprilat Dihydrate: 500mg Please Inquire Please Inquire
Enalaprilat Dihydrate: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Enalaprilat Dihydrate

Number of papers citing our products

Chemical structure

Enalaprilat Dihydrate

3D structure

Chemical Properties of Enalaprilat Dihydrate

Cas No. 84680-54-6 SDF Download SDF
PubChem ID 55286 Appearance Powder
Formula C18H28N2O7 M.Wt 384.42
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 100 mg/mL (260.13 mM)
H2O : 12.5 mg/mL (32.52 mM; Need ultrasonic)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-[2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]pyrrolidine-1-carboxylic acid;dihydrate
SMILES CC(C(=O)C1CCCN1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O.O.O
Standard InChIKey LRBNLIUVJIKAQR-UHFFFAOYSA-N
Standard InChI InChI=1S/C18H24N2O5.2H2O/c1-12(16(21)15-8-5-11-20(15)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13;;/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25);2*1H2
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Enalaprilat Dihydrate

DescriptionEnalaprilat is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 1.94 nM. Target: ACE Enalaprilat has high affinity for human endothelial ACE with IC50 of 1.94 nM in vitro binding assay by displacing a saturating concentration of [125I]351A, a radiolabeled lisinopril analogue from ACE binding sites, and shows bradykinin/angiotensin I selectivity ratio of 1.00 calculated from double displacement experiments [1]. Enalaprilat attenuates the IGF-I induced neonatal rat cardiac fibroblast growth (30% reduction) in a concentration-dependent fashion, with IC50 of 90 mM [2]. Administration of Enalaprilat induces a significant reduction of MAP at 70 minutes compared with the placebo group during haemorrhagic shock in rats, and results in a 50% reduction of CO, a general tendency of EB extravasation which is significant in the kidney and lungs, and a significant increase in ileal EB extravasation (53%) [3].

References:
[1]. Ceconi, C., et al., Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol, 2007. 577(1-3): p. 1-6. [2]. van Eickels, M., H. Vetter, and C. Grohe, Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation. Br J Pharmacol, 2000. 131(8): p. 1592-6. [3]. Schumacher, J., et al., Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats. Br J Anaesth, 2006. 96(4): p. 437-43.

Enalaprilat Dihydrate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Enalaprilat Dihydrate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Enalaprilat Dihydrate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.6013 mL 13.0066 mL 26.0132 mL 52.0264 mL 65.033 mL
5 mM 0.5203 mL 2.6013 mL 5.2026 mL 10.4053 mL 13.0066 mL
10 mM 0.2601 mL 1.3007 mL 2.6013 mL 5.2026 mL 6.5033 mL
50 mM 0.052 mL 0.2601 mL 0.5203 mL 1.0405 mL 1.3007 mL
100 mM 0.026 mL 0.1301 mL 0.2601 mL 0.5203 mL 0.6503 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Enalaprilat Dihydrate

Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 1.94 nM.

Featured Products
New Products
 

Description

Enalaprilat dihydrate (MK-422) is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 1.94 nM.

Keywords:

Enalaprilat Dihydrate,84680-54-6,Natural Products,ACE, buy Enalaprilat Dihydrate , Enalaprilat Dihydrate supplier , purchase Enalaprilat Dihydrate , Enalaprilat Dihydrate cost , Enalaprilat Dihydrate manufacturer , order Enalaprilat Dihydrate , high purity Enalaprilat Dihydrate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: